Eculizumab in Asian patients with anti-aquaporin-IgG-positive neuromyelitis optica spectrum disorder: A subgroup analysis from the randomized phase 3 PREVENT trial and its open-label extension

Publication date: Available online 20 February 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Ho Jin Kim, Ichiro Nakashima, Shanthi Viswanathan, KaiChen Wang, Shulian Shang, Larisa Miller, Marcus Yountz, Dean M. Wingerchuk, Sean J. Pittock, Michael Levy, Achim Berthele, Natalia Totolyan, Jacqueline Palace, Michael H. Barnett, Kazuo Fujihara (senior)
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research